论文信息 - Matrix metalloproteinase 9 is decreased in natalizumab‐treated multiple sclerosis patients at risk for progressive multifocal leukoencephalopathy - 字舞流文

Matrix metalloproteinase 9 is decreased in natalizumab‐treated multiple sclerosis patients at risk for progressive multifocal leukoencephalopathy

X. Montalban | P. Vermersch | S. Vukusic | M. Comabella | D. Brassat | S. Pérez-Hoyos | T. Moreau | J. Pelletier | A. Tourbah | P. Clavelou | P. Labauge | C. Papeix | A. Ruet | C. Lebrun-Frénay | J. Triviño | Nicolás Fissolo | J. Seze | C. Matute-Blanch | Alex Sánchez | B. Pignolet | B. Miró | M. Mota | Laurent Almoyna | Clara Matute-Blanch | Juan Carlos Triviño